NASDAQ: ARQT

Should investors be concerned about ARQT’s high price-to-sales ratio?
Arcelia Reed
Arcutis Biotherapeutics Inc (ARQT)’s stock is trading at $23.99 at the moment marking a fall of -4.43% from the last ...

ARQT’s price-to-book ratio: An indicator of the company’s performance
Patricia Turner
Arcutis Biotherapeutics Inc (ARQT)’s stock has witnessed a price declined of -3.25% from the previous close with its current price ...





